Status:
COMPLETED
Effect of Food Intake on Pharmacokinetic Profiles of Z-338
Lead Sponsor:
Astellas Pharma Inc
Conditions:
Healthy
Eligibility:
MALE
20-44 years
Phase:
PHASE1
Brief Summary
To evaluate the effects of food intake on plasma concentration of Z-338 in healthy volunteers.
Detailed Description
The purpose of the study is to evaluate the influence of food intake on the pharmacokinetic profiles of Z-338 in healthy volunteers by a 3-way cross-over method.
Eligibility Criteria
Inclusion
- Healthy subject
- Body weight: 50.0 - 80.0 kg
- BMI: 17.6 - 26.4
Exclusion
- Receiving an investigational new drug within 120 days of the study
- Receiving medical treatment drugs within 7 days of the study
- Blood donation before the study
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00920998
Start Date
March 1 2009
End Date
June 1 2009
Last Update
July 20 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kyushu, Japan